CAM
CBAY

Connacht Asset Management’s Cymabay Therapeutics CBAY Stock Holding History

Connacht Asset Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		$179K Sell
11,986
-22,549
-65% -$336K 1.06% 45
2023
Q2 		$378K Sell
34,535
-4,592
-12% -$50.3K 0.52% 42
2023
Q1 		$341K Buy
+39,127
New +$341K 0.15% 52